The North America brain health supplements market size is expected to be valued at US$ 3.0 billion in 2026 and projected to reach US$ 5.3 billion by 2033, growing at a CAGR of 8.4% between 2026 and 2033. The rising prevalence of neurological and cognitive decline conditions, heightened consumer focus on preventive mental wellness, and an aging Baby Boomer demographic seeking science-backed cognitive support solutions.

According to the Alzheimer's Association, more than 6.9 million Americans aged 65 and older are living with Alzheimer's disease in 2024, creating urgent demand for preventive and supportive brain health nutrition. Simultaneously, the post-pandemic surge in consumer awareness of mental performance optimization driven by high-stress work environments and increased screen time is expanding the addressable market beyond seniors into the 18-45 adult demographic, fueling innovation in nootropics, adaptogens, and functional brain supplement formats.

Drivers - The growing prevalence of conditions like Alzheimer’s and MCI boosts interest in neuroprotective solutions

The increasing prevalence of cognitive and neurological conditions is a major driver in the North America brain health supplements market. As aging population expands, so does the demand for preventive and neuroprotective solutions. According to the Alzheimer’s Association®, an estimated 7.2 million Americans aged 65 and older are projected to be living with Alzheimer’s dementia in 2025, highlighting a critical public health concern.

In Canada, the government reported that over 5 million individuals aged 15 and older, about 18% of the population, met the diagnostic criteria for mood, anxiety, or substance use disorders in 2022. These rising incidences of cognitive decline and mental health challenges are prompting consumers to seek science-backed supplements that support memory, focus, and emotional balance. As awareness grows, the market is witnessing increased interest in natural, preventive strategies to maintain brain function and quality of life.

Restraints - Risk of warning letters or product recalls from regulatory bodies

The risk of regulatory scrutiny poses a significant restraint in the North America brain health supplements market. Companies face potential setbacks from warning letters, product recalls, or enforcement actions when products make unsubstantiated health claims or fail to comply with labeling and safety standards. In 2021, the U.S. Food and Drug Administration (FDA) issued warnings to 10 companies for illegally marketing dietary supplements that claimed to cure, treat, mitigate, or prevent depression and other mental health disorders. Such actions highlight the stringent oversight governing the supplement industry, particularly regarding cognitive and psychological health claims. These regulatory pressures damage brand credibility and also lead to financial losses and consumer distrust, urging companies to ensure scientific backing and compliance in all marketing and product development efforts.

Opportunities - Personalized Brain Health Nutrition and Direct-to-Consumer Digital Platform Expansion

The convergence of personalized nutrition technology with brain health supplementation represents a transformative long-term market opportunity. Digital health platforms offering DNA-based, microbiome-based, and cognitive assessment-driven supplement recommendations are gaining traction among health-conscious North American consumers. Herbalife and Nestlé Health Science S.A. are investing in personalized nutrition digital interfaces that incorporate cognitive health biomarkers.

According to the International Food Information Council (IFIC) 2023 Food & Health Survey, 51% of Americans are interested in personalized dietary recommendations, a significant addressable audience for AI-driven brain supplement subscription services. The DTC subscription model, enabling recurring revenue, consumer data collection for product iteration, and higher lifetime customer value, is being pioneered by brands including BrainMD Health and Life Extension, offering a high-margin business model complementing traditional retail distribution.

Product Type Insights

The Omega-3 segment leads the North America brain health supplements market by product type, commanding ~28% of total market share in 2025. Omega-3 fatty acids, particularly DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) have the most robust scientific evidence base among all brain health supplement ingredients, with the American Heart Association (AHA) and NIH Office of Dietary Supplements both acknowledging DHA's critical role in brain structure and function. A landmark meta-analysis published in Nutrients (2022) demonstrated that Omega-3 supplementation was associated with improvements in memory and executive function in older adults. Omega-3s ' broad consumer recognition, driven by decades of mainstream marketing by brands including NOW Foods and Solgar Inc. and availability across mass-market retail and pharmacy channels sustain its leading position. Nootropics are the fastest-growing segment, driven by working-age adult demand for cognitive performance enhancement.

Form Insights

The capsules segment leads the North America brain health supplements market by form, accounting for ~39% of total market share in 2026. Capsules' dominance reflects their universal compatibility with diverse active ingredients, including oils (fish oil, algal DHA), powdered botanical extracts, and amino acid blends combined with consumer familiarity, precise dosing, rapid dissolution, and clean label presentation without artificial binders or coatings.

Leading brands, including Life Extension, Solgar Inc., and Researched Nutritionals, deliver their flagship brain health formulations primarily in capsule format, reinforcing the segment's mainstream positioning. Additionally, the FDA's Current Good Manufacturing Practice (cGMP) regulations under 21 CFR Part 111 are well-established for capsule production, reducing regulatory compliance complexity for manufacturers. Gummies & Softgels are the fastest-growing form segment, driven by palatability-focused innovation among the 25-45 adult consumer cohort.

Sales Channel Insights

The pharmacy/drug store channel leads North America brain health supplements market distribution, accounting for ~33% of total sales revenue in 2026. Pharmacies, including CVS Health, Walgreens, and Rite Aid serve as trusted health destination points for cognitive supplement shoppers, particularly among the senior demographic that values pharmacist guidance in supplement selection. The pharmacy channel's health-authority positioning enables premium shelf placement and in-store consultative selling for brain health supplement brands. Online Retail is the fastest-growing sales channel, driven by the rapid expansion of health-focused e-commerce platforms, including Amazon, iHerb, and brand DTC websites. Online retail enables superior product assortment breadth, consumer review visibility, subscription purchasing models, and precision-targeted digital marketing, making it the preferred channel for nootropic and premium specialty brain health supplement brands, including BrainMD Health and Onnit Labs, Inc.

U.S. Brain Health Supplements Market Trends and Insights

The U.S. dominates the North America Brain Health Supplements market with ~87% of total regional market share in 2026, reflecting its position as the world's largest dietary supplement market. The U.S. market benefits from a highly developed regulatory framework under DSHEA, a mature retail infrastructure spanning pharmacy chains, specialty health retailers, and dominant e-commerce platforms, and exceptionally high consumer supplement usage rates, with 74% of U.S. adults using dietary supplements according to the CRN 2023 Survey.

Key market trends include the mainstreaming of nootropic stacks from gym and biohacker subcultures into mass-market retail, the rise of celebrity-endorsed and influencer-driven brain supplement brands, increasing retail pharmacy promotion of pharmacist-recommended cognitive health programs, and growing Medicaid and Medicare Advantage wellness benefit coverage extending to OTC supplement reimbursement. Companies including GNC Holdings, LLC, NOW Foods, and OLLY Vitamins & Supplements have built extensive national distribution networks across the U.S., anchoring the market's commercial scale.

Canada Brain Health Supplements Market Size

Canada’s brain health supplements market is gaining momentum as mental health awareness and preventive wellness become national priorities. According to the Canadian Mental Health Association, Canadians spend nearly $950 million annually on private psychologists, with 30% of that paid out-of-pocket, underscoring a willingness to invest in cognitive wellness. In February 2025, Brain Canada Foundation and CQDM launched a joint initiative to accelerate biopharma innovation in brain disorder treatment, reflecting institutional commitment to neurological health.

Consumer interest in natural health products (NHPs) continues to rise, driven by a shift toward proactive mental well-being. Online platforms and social media now serve as key discovery and educational tools, especially among younger demographics. National mental health events are fostering open conversations, encouraging supplement use as part of a holistic approach. Altogether, these trends position Canada as a fast-growing, innovation-friendly market for brain health supplements rooted in science and accessibility.

North America brain health supplements market is highly competitive and rapidly evolving, characterized by a diverse mix of players from established pharmaceutical and nutraceutical giants to agile startups and niche brands. With consumers seeking targeted cognitive benefits such as memory, focus, mood enhancement, sleep support, and anti-aging, companies are formulating products with varied ingredients, including herbal extracts, vitamins, minerals, and nootropics. This variety supports market segmentation and niche penetration. Intense competition drives continuous innovation, evident in strong R&D pipelines, strategic partnerships, and bold marketing strategies.

The rise of e-commerce has further democratized access, enabling smaller brands to reach consumers directly. While stringent regulatory oversight ensures product safety and efficacy, government-backed initiatives promoting mental wellness and advancing clinical research contribute to consumer trust and market expansion. Altogether, the outlook for this dynamic and opportunity-rich market remains highly positive across the region

Key Developments:

• In September 2025, Neuriva, a leading brain health supplement brand by Reckitt, launched Neuriva Memory 3D, an advanced formula developed to support three essential memory functions: short-term, long-term, and working memory.
• In May 2025, Olympian and former World Tour professional cyclist Dave Zabriskie announced the launch of Cognitive Protocol, an initiative focused on recovery from concussions and closing gaps on cognitive health and treatment in sports injuries.
• In January 2025, Fenix Health Science introduced a new personalized product line in January 2025 focused on cognitive health across all life stages. The innovative Omega products feature LYSOVETA® LPC, a cutting-edge technology that reportedly delivers up to 297% more omega-3s to the brain per dose compared to traditional fish oil, promising enhanced cognitive support.
• In February 2024, BrainMD introduced Smart Collagen, a brain and body-supporting supplement developed under the leadership of Dr. Daniel G. Amen.